The story of Micro Labs Limited cannot unfold without the story of our founder and inspirational leader, Mr. G C Surana.
He had a humble beginning with a Pharmaceutical Distributor in Bangalore. With valuable years of experience behind him and dedication towards hard work, Mr. Surana began a marketing and distribution agency for a Delhi-based pharmaceutical company. The agency handled the distribution of medicines for the southern states of India.
Formed an Advisory Board for Fever Management. It is an independent autonomous body focused towards the study on different epidemiology of fever.
The company later became the majority stakeholder in RA Chem Pharma.
First product launch in the US.
First product launch in Europe.
Micro Labs US was incorporated in the year 2011.
The company establishes a state-of-the-art ophthalmic plant. It is the first of its kind in Asia, leading to a collaboration with Bausch+Lomb.
Micro Labs inaugurated a new facility in Vema industrial area, Goa for export markets and was approved by the US FDA, EU, and other regulated countries.
A dedicated plant began production at Veerasandra Industrial Area, Bangalore specialised in handling Penicillin-based products.
A manufacturing unit in Kumbalgodu Industrial Area in Bangalore was established in 2000.
Micro Labs established a new manufacturing unit – Micro Nova Pharmaceutical Pvt Ltd, at Peenya Industrial area, Bangalore.
In August 1999, a new unit was setup under the flagship of Micro Labs Ltd. in Pondicherry.
The company’s first foray into the export: Sri Lanka/Nigeria/Qatar.
The company established a second manufacturing unit at Hosur, Tamil Nadu.
Micro Labs Ltd was founded by Late Shri G.C. Surana to manufacture ethical pharmaceutical products with a manufacturing facility in Chennai.
In addition to the above, we also have 2 new state-of-the-art facilities located at Baddi and Sikkim.
Today, Micro Labs is a multi-faceted organization with an annual turnover of Rs.4083 crore (2020-2021). The company has 14 oral formulation plants including an injectable unit; a bulk drug facility, offices located overseas, and a strong distribution network. Our marketing efforts span into 22 divisions, with each division specialized to cater to various therapeutic segments.
The organization’s most important component, however, remains its 11790 dedicated employees.
With state-of-the-art facilities and R&D centers designed to international standards, Micro Labs is poised to become a respected global brand in the pharmaceutical field and highlight our nation’s growing reputation.
Today, the company has 22 marketing divisions catering to the leading therapeutic segments such as Cardiology, Diabetology, Pain management, Dermatology, Veterinary, Neurology, etc.